JPMIA
INFI

J.P. Marvel Investment Advisors’s Infinity Pharmaceuticals, Inc. INFI Stock Holding History

J.P. Marvel Investment Advisors’s Portfolio INFI Stock Details INFI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-51,390
Closed -$271K – 85
2016
Q1 		$271K Hold
51,390
– – 0.1% 76
2015
Q4 		$403K Buy
+51,390
New +$442K 0.14% 69
2015
Q2 		$578K Hold
52,830
– – 0.19% 68
2015
Q1 		$739K Hold
52,830
– – 0.25% 59
2014
Q4 		$892K Buy
+52,830
New +$769K 0.31% 59

Other funds holding INFI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

J.P. Marvel Investment Advisors's INFI Position: Q2 2016 in Review

J.P. Marvel Investment Advisors sold out of Infinity Pharmaceuticals, Inc. (INFI) in Q2 2016, closing a stake of 51,390 shares — an estimated $271K sold.

J.P. Marvel Investment Advisors first reported a position in INFI in Q4 2014 and held it in 5 quarters. The position peaked at $892K in Q4 2014. 107 funds tracked by Wall St. Rank hold INFI as of Q2 2016.

  • J.P. Marvel Investment Advisors reported no remaining Infinity Pharmaceuticals, Inc. position as of Q2 2016 after selling out during the quarter.
  • J.P. Marvel Investment Advisors sold 51,390 Infinity Pharmaceuticals, Inc. shares in Q2 2016, an estimated $271K.
  • J.P. Marvel Investment Advisors first reported a position in Infinity Pharmaceuticals, Inc. in Q4 2014 and held it in 5 quarters.
  • J.P. Marvel Investment Advisors's Infinity Pharmaceuticals, Inc. position peaked at $892K in Q4 2014.
  • 107 funds tracked by Wall St. Rank held Infinity Pharmaceuticals, Inc. as of Q2 2016.

Based on J.P. Marvel Investment Advisors's 13F filing for Q2 2016, filed 15 Aug 2016.